CD8A and neoplasm: AdCMVmCD40L therapy can induce strong lymphocyte infiltration in tumor tissues and increase the apoptosis of malignant cells. The observed anti-tumor effect is mediated by CD8+ T cells and is related to increased serum levels of interleukin (IL)-12 and enhanced natural killer (NK) activity.